Medical Monitoring Equipment With Microbiome Therapeutics For Clinical Trials Applications
1 equipment items found
-
Manufactured by Finch Therapeutics Group, Inc.based in USA
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most urgent antibiotic resistant threats and the most common cause of healthcare associated infection in the United ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you